NY-CIRIUM
27.10.2021 14:02:17 CEST | Business Wire | Press release
The new DiioTM Schedule Snapshot offering released by Cirium, the aviation analytics firm, reveals how planning by the major US airlines changed over the summer, with 20% of flights being removed from their schedule for September.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211027005581/en/
At the start of May 2021, the plan for what carriers would fly in September was more or less in line with pre-pandemic levels in 2019. By the time they came to fly the September schedule, American Airlines, Delta Air Lines, Southwest and United Airlines had significantly cut back their flights.
Airlines are now making major changes to the way they schedule flights—publishing or removing them much closer to the date of departure as they struggle with the uncertainties brought on by the pandemic.
Prior to the pandemic schedules would remain fairly stable over a season, with few changes—positive or negative—as the plan was refined.
Only 3% of flights were removed from the September schedule in 2019 compared with the plan published in May that year.
The new Diio Schedule Snapshot web-based tool enables airlines and airports to track changes to the flights being scheduled at different points in time. It provides much more detail on schedule changes than has been done in the past.
“In today's environment where travel restrictions and vaccination programs are significantly impacting flight schedules, airlines have had to adapt and issue changes to their schedules frequently and much closer to the day of departure. The traditional methods used to analyze demand need to be more dynamic,” said Kevin O’Toole, Chief Strategy Officer at Cirium.
“Using Diio Schedules Snapshot, airlines and airports can understand schedule changes over time, optimize future schedules, build stronger models for planning and revenue management, and optimize yield through trend analysis.”
The analysis of the major US airlines evidences the radical shift in the summer flight schedule and the impact that the pandemic has had on the variance in airline planning year-over-year.
Understanding and comparing changes to the published flight schedule over time as it gets closer to actual departure, enables analysts to stay ahead of the curve, and provides new insights for planning and revenue management.
Reviewing historical data by publication date also provides insights on airline and airport strategies in an uncertain world.
Diio Schedule Snapshot is part of the unrivaled Cirium Diio suite of products for airline planning. The suite includes Diio Mi, SRS AnalyserTM , Cirium Scenario Planner, and Diio Traffic and Fares.
The new tool integrates with Cirium Diio Mi or SRS Analyser and is the first of many more new tools in the Cirium pipeline to help airlines optimize their schedules and find new revenue opportunities.
More information on Diio Schedule Snapshot can be found at https://cirium.com/products/views/diio-schedule-snapshot
-End-
For further information please visit https://www.cirium.com and follow Cirium updates via LinkedIn and Twitter.
About Cirium
Cirium brings together powerful data and analytics to keep the world moving. Delivering insight, built from decades of experience in the sector, enabling travel companies, aircraft manufacturers, airports, airlines and financial institutions, among others, to make logical and informed decisions which shape the future of travel, growing revenues and enhancing customer experiences. Cirium is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. The shares of RELX PLC are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211027005581/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Arthur D. Little: H1 2026 Private Capital Fundraising Strengthens While Market Sentiment Highlights Investor Shift to Europe over US and Asia5.11.2026 18:58:00 CET | Press release
H1 fundraising up 6% year-on-year as 43% of LPs see geopolitical volatility favouring European funds AI usage dominates industry attention, defence leads target investment themes Invest Europe, the association representing Europe’s private equity, venture capital and infrastructure sectors, as well as their investors, today released ‘Investing in Europe: Private Equity Activity H1 2026’ and ‘The Insight: State of the European Private Equity Industry 2026’, an annual market sentiment report published jointly with global management consultancy Arthur D. Little (ADL). Together, these show increased fundraising for European private equity and venture capital versus the same period last year, stronger investor allocation expectations for Europe, and declining appetite for the US and Asia. The sentiment report also demonstrates how AI is reshaping the industry and portfolio companies, while defence-related themes are topping GPs’ target investments. GPs (General Partners/fund managers of PE
Angelalign Appoints Marco Gadola as Senior Advisor5.11.2026 18:35:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel”) http://www.angelaligner.com, a global clear aligner leader, today announced that Marco Gadola has joined Angel as Senior Advisor. In this role, Marco will advise the Board and senior management on culture, strategy and governance. Marco, who has held many leadership positions, is well-known as a former CEO of Straumann Group, a leading global medical device company focused on dentistry. Marco said he is excited to join Angel. “I’ve followed Angel for 10 years and have seen how it has evolved,” he said, “It’s grown from a regional leader in innovative clinical solutions and high-quality products, to a worldwide organization trusted by orthodontic specialists, with an impressive innovation pipeline.” Fox Hu, CEO of Angel, said: “Angel has strong core capabilities, but we must continue to improve to serve orthodontists even better. We welcome Marco as an advocate for our customers and employees around the world and to help us build an outstan
Boomi Named a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms5.11.2026 17:25:00 CET | Press release
Boomi governs agents, with flexibility across cloud, hybrid, and fully on-premises deployments behind the firewall. Boomi, the data activation company for AI, today announced it has been recognized as a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms. Boomi delivers agent management capabilities through the Agent Control Plane. Boomi believes this placement reflects its approach to solving one of the biggest hurdles in turning AI into ROI, by providing critical AI infrastructure that connects, governs, and controls AI costs across agents and skills from native and third-party providers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105515847/en/ Boomi Named a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms Key Takeaways Boomi has been recognized as a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms. A complimentary copy of t
Biocodex Invests €15 Million in a New Industrial Platform for Live Biotherapeutic Products5.11.2026 16:04:00 CET | Press release
Biocodex, an independent French pharmaceutical company, announces a €15 million investment to develop an industrial platform in Beauvais, France, dedicated to Live Biotherapeutic Products (LBPs) derived from the microbiome. Building on more than 70 years of expertise in living microorganisms, microbiota, fermentation and pharmaceutical manufacturing, Biocodex aims to support its partners and, ultimately, its own programs, from research through to clinical and commercial production. The project aims to strengthen healthcare and industrial sovereignty in the field of next-generation microbiome-based therapies. Scientific advances in microbiome science are opening up new therapeutic perspectives, notably in oncology, inflammatory bowel diseases, certain rare diseases and women’s health. Moving from research to pharmaceutical production requires facilities adapted to living microorganisms and pharmaceutical requirements. Open to biotechnology companies worldwide, it will support LBP progra
Experian's New Documentary RECLAIM Shows How Financial Access and Innovation Are Creating Opportunity Around the World5.11.2026 16:00:00 CET | Press release
Short film follows consumers across three countries whose stories demonstrate the power of financial inclusion, innovation and resilienceKey highlights: New Experian documentary features five individuals from the United States, Brazil and the United Kingdom whose experiences illustrate the impact of financial access and opportunity. Documentary highlights examples spanning debt relief, financial education, credit empowerment and healthcare innovation. Stories showcase how Experian's products, services and social innovation can help consumers navigate challenges and pursue personal and financial goals. For years, Almir dreamed of meeting his granddaughter in the United States. But unresolved debt stood in the way. Thousands of miles away in Arizona, Elizabeth faced mounting medical expenses after a health crisis. In London, Rochelle worked to regain control of her finances while caring for family members. Their stories, and others like them, are at the heart of RECLAIM: Stories of Passi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
